- Home
- BARK vs ENGN Comparison
BARK vs ENGN Comparison
Compare BARK & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- ENGN
- Stock Information
- Founded
- BARK 2011
- ENGN 1999
- Country
- BARK United States
- ENGN Canada
- Employees
- BARK N/A
- ENGN N/A
- Industry
- BARK Department/Specialty Retail Stores
- ENGN
- Sector
- BARK Consumer Discretionary
- ENGN
- Exchange
- BARK Nasdaq
- ENGN Nasdaq
- Market Cap
- BARK 308.9M
- ENGN 317.6M
- IPO Year
- BARK N/A
- ENGN N/A
- Fundamental
- Price
- BARK $1.90
- ENGN $6.32
- Analyst Decision
- BARK Buy
- ENGN Strong Buy
- Analyst Count
- BARK 2
- ENGN 9
- Target Price
- BARK $2.20
- ENGN $29.78
- AVG Volume (30 Days)
- BARK 1.3M
- ENGN 206.9K
- Earning Date
- BARK 02-05-2025
- ENGN 12-19-2024
- Dividend Yield
- BARK N/A
- ENGN N/A
- EPS Growth
- BARK N/A
- ENGN N/A
- EPS
- BARK N/A
- ENGN N/A
- Revenue
- BARK $488,881,000.00
- ENGN N/A
- Revenue This Year
- BARK $3.23
- ENGN N/A
- Revenue Next Year
- BARK $10.01
- ENGN N/A
- P/E Ratio
- BARK N/A
- ENGN N/A
- Revenue Growth
- BARK N/A
- ENGN N/A
- 52 Week Low
- BARK $0.74
- ENGN $4.42
- 52 Week High
- BARK $2.56
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- BARK 45.11
- ENGN 36.76
- Support Level
- BARK $1.84
- ENGN $5.60
- Resistance Level
- BARK $2.26
- ENGN $6.54
- Average True Range (ATR)
- BARK 0.14
- ENGN 0.67
- MACD
- BARK -0.06
- ENGN -0.14
- Stochastic Oscillator
- BARK 8.39
- ENGN 22.43
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.